Can Intuitive Surgical survive the emerging competition?

It will be interesting to see. I'm not convinced that the future of robotic surgery can sustain multiple platforms. MDT and Verb probably based their revenue models on ISI, the problem being that hospitals are currently losing their collective asses on the inflated cost of robotic procedures. The market will eventually correct, and when it does, robotic surgery will be far less profitable for OEMs in the space.

More players = more competitions = more innovations and hopefully it will lead to lower price???
 






















































It's not a secret. It's the elephant in the room. Hospitals know that using the robotic is a luxury and that it's driving up costs, but everyone pretends it's not happening. Instead, they feel compelled to perform basic surgery using davinci to justify all the money being wasted on buying/leasing and maintaining multiple systems. Pretty sweet little racket Intuitive has created.

Can’t wait for Ethicon’s and MDT’s robots to come out. It will reduce the cost per procedure significantly compared to da Vinci.
 






Can’t wait for Ethicon’s and MDT’s robots to come out. It will reduce the cost per procedure significantly compared to da Vinci.

That’s too bad, cause you’re gonna have to wait several years before either of these appear in the US. Not sure that it will dramatically reduce cost either. After investing billions to develop robotic platforms, I don’t see EES or MDT trying to low-ball the market.
 






That’s too bad, cause you’re gonna have to wait several years before either of these appear in the US. Not sure that it will dramatically reduce cost either. After investing billions to develop robotic platforms, I don’t see EES or MDT trying to low-ball the market.

Both ETH and MDT have been losing and will continue to decline on share to ISRG. By the time their robots are out they will be desperate to gain that share back from ISRG.
 






Both ETH and MDT have been losing and will continue to decline on share to ISRG. By the time their robots are out they will be desperate to gain that share back from ISRG.

All true, but I would be amazed if either of their robotic platforms are substantially less expensive than daVinci. It makes no sense to dilute the potential value of their robotic offering, and MDT and J&J have a huge bag of products that it can pull through.